Framingham Heart Study
Level 5 - mechanism / opinion, no new human data
Narrative overview and historical review paper with no new primary human data or systematic synthesis methodology.
OpenAlex W3165429330 · doi:10.1016/j.jacc.2021.01.059
What was done
This paper presents an overview of the Framingham Heart Study (initiated in 1948), detailing its cohort structures—which include three generations of White participants and two cohorts of racial and ethnic minority participants—along with its phenotypic data collection, longitudinal follow-up protocols, and molecular epidemiology advancements.
What was found
The abstract reports no quantitative results, sample sizes, or statistical metrics. It qualitatively summarizes that the study provides continuous data on human cardiovascular and noncardiovascular physiology across the lifespan and identifies major cardiovascular disease risk factors.
Why it matters
It outlines the history, structure, and foundational contributions of the longest-running cardiovascular cohort study, highlighting its transition into modern molecular epidemiology.
Limits
The abstract contains no numerical findings or effect sizes. As an overview paper, it synthesizes broad historical and ongoing cohort operations rather than testing a specific hypothesis. Additionally, the study historically centered on three generations of White participants before incorporating two minority cohorts.
Cited by
- supports The Framingham Heart Study began longitudinal data collection in Massachusetts in 1948.